51885-79-1

Basic information

• Product Name: 4-Ethyl-3-nitro-benzoic acid Methyl ester
• Synonyms: 4-Ethyl-3-nitro-benzoic acid Methyl ester;Methyl 4-Ethyl-3-Nitrobenzoate;Benzoic acid, 4-ethyl-3-nitro-, methyl ester
• CAS NO: 51885-79-1
• Molecular Formula: C₁₀H₁₁NO₄
• Molecular Weight: 209.19864
• EINECS: -0
• Mol File: 51885-79-1.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 314.6±30.0 °C(Predicted)
• Appearance: /
• Density: 1.216±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 4-Ethyl-3-nitro-benzoic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Ethyl-3-nitro-benzoic acid Methyl ester(51885-79-1)
• EPA Substance Registry System: 4-Ethyl-3-nitro-benzoic acid Methyl ester(51885-79-1)

Safety Data

• Hazardous Substances Data: 51885-79-1(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 103440-95-5 4-Ethyl-3-nitrobenzoic acid 
• 4748-80-5 4-ethyl-3-nitro-benzaldehyde 
• 619-64-7 p-ethylbenzoic acid 
• 124-41-4 sodium methylate 

Downstream Products

• 24812-93-9 3-amino-4-ethylbenzoic acid methyl ester 
• 702643-06-9 methyl 4-(2-hydroxy-1-methylethyl)-3-nitrobenzoate 
• 748789-30-2 C₁₂H₁₂ClNO₆ 
• 88072-25-7 4-Ethyl-3-(2-oxo-azetidin-1-yl)-benzoic acid 
• 88072-07-5 3-(3-Bromo-propionylamino)-4-ethyl-benzoic acid methyl ester 
• 88072-17-7 4-Ethyl-3-(2-oxo-azetidin-1-yl)-benzoic acid methyl ester 
• 103441-03-8 3-iodo-4-ethyl-benzoic acid 
• 51885-92-8 4-Ethyl-3-d-benzoic acid 
• 51885-91-7 methyl 4-ethyl-3-iodobenzoate 
• 1449668-98-7 C₁₇H₁₈N₄O₂ 
• 201286-95-5 6-(methoxycarbonyl)-3-methyl-1H-indazole 
• 1081551-72-5 methyl 3-chloro-4-ethylbenzoate 
• 1427395-09-2 (3-chloro-4-ethylphenyl)methanol 
• 868211-93-2 methyl 4-ethyl-3-fluorobenzoate 

Relevant articles and documents

SMALL MOLECULE MODULATORS OF HUMAN STING

The present invention relates to compounds of formula (I). The compounds maybe used to modulate the Stimulator of Interferon Genes (STING) protein and thereby treat diseases such as cancer and microbial infections.

HISTONE DEMETHYLASE INHIBITORS

Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, wherein R1 and Cy are as disclosed herein. These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.